MONDAY, OCTOBER 23, 2017

Immune response high in Ebola survivors

Findings of Emory study could help develop vaccine. Read More »

Novel vaccine may prevent herpes

A team of researchers at Howard Hughes Medical Institute (HHMI) of Albert Einstein College of Medicine have developed a mutant gene that lacks a herpes protein, creating a vaccine that may prevent herpes viruses. Read More »

Takeda transfers HPV vaccine license to Kaketsuken

Takeda Pharmaceutical Company, Ltd., has recently¬†transferred its license agreement for a vaccine for human papillomavirus (HPV) to Kaketsuken, the Chemo-Sero-Therapeutic Research Institute. Read More »

Madison Vaccines expands investigational prostate cancer vaccines

According to a recent report from Madison Vaccines Incorporated (MVI), a clinical stage biopharmaceutical company that creates novel therapies for prostate cancer, will expand three of its prostate cancer vaccine projects. Read More »

India commercially launches ROTAVAC vaccine

According to a recent report from Hyderabad-based Bharat Biotech, Shri NarendraModi (Prime Minister of India) recently launched the ROTAVAC vaccine, which is made in India. Read More »

Novavax names Brian Rosen VP of Government Affairs

Brian Rosen will lead vaccine company's policy and government affairs efforts. Read More »

Clinical studies challenged with decrease in Ebola cases

Not enough study participants available to test possible new vaccines. Read More »

WHO, World Food Programme join forces to fight Ebola

Goal of partnership is to reach zero cases of deadly virus in West Africa. Read More »

NIH creates database of healthy immune traits

Database will serve as reference resource for other researchers. Read More »

Mississippi confirms 1st pediatric death of the flu season

A report from the Mississippi State Department of Health (MSDH) recently confirmed the first pediatric death from influenza for the flu season of 2014-2015. Read More »

New flu strains prove difficult to contract

A recent study by The Scripps Research Institute (TSRI) revealed evidence that two new influenza strains are not easy for humans to contract, making a pandemic unlikely. Read More »

Majority of parents still seeking vaccinations for children

Harvard study shows routine vaccinations remain the norm. Read More »

University of Adelaide to continue monitoring flu activity in Australia

Government extends new contract with school until January 2017. Read More »

Immunicum shares cancer vaccine update

INTUVAX shows promise in Phase I/II study Read More »

Delaware confirms Vancomycin-resistant Staphylococcus aureus case

New Castle County patient has rare infection Read More »

4 strains in flu vaccine prove more effective than 3

Study by Saint Louis University researchers parallel earlier findings. Read More »

Nanoparticles may be best bet for treating respiratory infections

Minute particles can deliver antibiotics directly to infected cells. Read More »

British health officials encourage all teens to receive meningitis vaccine

Increase in number of rare, but deadly meningitis W cases leads to call to action. Read More »

Newly discovered therapeutic vaccine for rabies

Yisheng Biopharma Co., Ltd., a biopharmaceutical company that researches, creates and sells vaccine products, recently created a new rabies vaccine. Read More »

Human health highlighted in global disaster prevention plan

Representatives from governments around the world recently met in Sendai to discuss an outline for global action that hopes to decrease the chances of disasters. Read More »